SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-16-630241
Filing Date
2016-06-23
Accepted
2016-06-23 17:29:03
Documents
2
Group Members
ARNOLD L. ORONSKYBRUCE A. CLEVELANDGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS IX, LLCKHALED A. NASRPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d218736dsc13da.htm SC 13D/A 162457
2 EX-99.A d218736dex99a.htm EX-99.A 8094
  Complete submission text file 0001193125-16-630241.txt   172467
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88797 | Film No.: 161729348
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

IRS No.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A